Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team.
During my research career, I became interested in different proteins involved in pathophysiological processes. Amongst them, the CD146 molecule, on which my team has worked for many years, is particularly exciting because it is both yin and yang, with involvement in many physiological processes such as angiogenesis or embryo implantation and, at the same time, a deleterious effect when expressed on tumour cells.
Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team. To achieve this, we combine multiple and cross-cutting approaches from genes to proteins, from animal model cell tissue to humans, and from fundamental research to clinical application. This requires the use of advanced technology from transcriptomics proteomics, through imagery and the generation of antibodies. Marseille Immunopole is an extraordinary melting pot that allows us to work with many experts and combine these different approaches, with the common goal to bring new tests and new drugs for the benefit of patients.#recherche
MI should enable us to accelerate discovery, enhance our treatment options and offer more innovative options to our patients through current clinical trials and those of the future.
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.
AMU, IPC, CRCM
MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.